Clinical Trials Browser

Carcinoma, Hepatocellular × peginterferon alfa-2b × Clear all

NCT05671315 2023-05-25

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis B, Chronic

NCT00759109 2017-04-07

Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085)

Phase 3 Completed

150 enrolled 12 charts

Gastrointestinal

Carcinoma, Hepatocellular